当前位置:首页 - 行情中心 - 千金药业(600479) - 财务分析

千金药业

(600479)

  

流通市值:45.16亿  总市值:53.11亿
流通股本:4.19亿   总股本:4.92亿

千金药业(600479)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至第三季度实现净利润2.58亿元,每股收益0.45元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至第三季度最新股东权益324440.10万元,未分配利润127327.07万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至第三季度最新总资产490091.94万元,负债165651.84万元。

利润表
报告期2025-09-302025-06-302025-03-312024-12-31
营业总收入2,718,335,546.61,817,998,691.421,005,023,395.383,629,804,492.14
营业总成本2,458,728,936.981,636,266,894.81922,900,905.53,317,463,364.57
其他经营收益
营业利润300,588,151.65195,294,528.7780,038,612.66332,110,652.19
利润总额298,712,363.67194,372,337.5179,470,987.37335,307,574.03
净利润258,232,870.24174,035,961.3972,319,004.16302,608,701.01
每股收益
其他综合收益524,130.45524,144.56--13,947.49
综合收益总额258,757,000.69174,560,105.9572,319,004.16302,594,753.52
资产负债表
报告期2025-09-302025-06-302025-03-312024-12-31
流动资产:
流动资产合计2,160,331,768.842,500,492,551.992,539,178,640.442,728,924,172.75
非流动资产:
非流动资产合计2,740,587,670.742,261,710,2022,122,110,290.041,827,373,904.98
资产总计4,900,919,439.584,762,202,753.994,661,288,930.484,556,298,077.73
流动负债:
流动负债合计1,540,001,752.771,516,729,020.741,365,133,748.561,332,793,102.67
非流动负债:
非流动负债合计116,516,690.3985,029,631.5782,689,619.9184,358,417.21
负债合计1,656,518,443.161,601,758,652.311,447,823,368.471,417,151,519.88
所有者权益(或股东权益):
归属于母公司股东权益合计2,501,527,329.332,441,890,460.912,517,440,737.22,462,279,280.07
股东权益合计3,244,400,996.423,160,444,101.683,213,465,562.013,139,146,557.85
负债和股东权益合计4,900,919,439.584,762,202,753.994,661,288,930.484,556,298,077.73
现金流量表
报告期2025-09-302025-06-302025-03-312024-12-31
经营活动产生的现金流量:
经营活动现金流入小计2,918,990,251.211,840,645,307.52892,802,082.874,038,542,875.24
经营活动现金流出小计2,676,021,875.311,885,112,377.021,017,170,9963,639,776,420.64
经营活动产生的现金流量净额242,968,375.9-44,467,069.5-124,368,913.13398,766,454.6
投资活动产生的现金流量:
投资活动现金流入小计4,119,4502,722,5002,400,0006,138,020.76
投资活动现金流出小计862,847,063.8425,957,906.49294,269,256.26747,320,542.82
投资活动产生的现金流量净额-858,727,613.8-423,235,406.49-291,869,256.26-741,182,522.06
筹资活动产生的现金流量:
筹资活动现金流入小计5,594,632.235,594,632.232,000,00016,282,452.37
筹资活动现金流出小计175,569,371.8124,448,341.01240,000266,403,772.6
筹资活动产生的现金流量净额-169,974,739.58-18,853,708.781,760,000-250,121,320.23
汇率变动对现金及现金等价物的影响----
现金及现金等价物净增加额-785,733,977.48-486,556,184.77-414,478,169.39-592,537,387.69
期末现金及现金等价物余额550,060,773.02849,238,565.73921,316,581.111,335,794,750.5
补充资料:
现金及现金等价物的净增加额--486,556,184.77--592,537,387.69
最新报告期:2025-09-05
研究机构分析师预测每股收益(元)更新日
2025年2026年2027年
招商证券梁广楷,欧阳京,许菲菲0.700.871.042025-09-05
TOP↑